Skip to main content
. 2019 Dec 3;10:2847. doi: 10.3389/fimmu.2019.02847

Table 11.

Clinical trials of JAKi in chronic hand eczema. cHE, chronic hand eczema according to clinicaltrials.gov.

Disease
type
Inhibitor Target Administration Phase Study number
cHE Delgocitinib PanJAK Topical Phase II NCT03683719
Delgocitinib PanJAK Topical Phase II NCT02664805